Ticker brief
TLSA
last close
·
1 day
·
14 days
·
mkt cap
·
signals 14d
6
authors 14d
5
crowd 14d
+0.7σ
No price history on file for this name (likely non-equity or unlisted) — the “since then” column below stays blank.
Sentiment — last 14 days
daily mean sentiment, 2026-10-03 → 2026-10-16 · now +0.12 (−1 bearish … +1 bullish)
Who spoke5
| author | grade | trader score | signals | mean sent |
|---|---|---|---|---|
| @BiopharmIQ | B | · | 2 | +0.12 |
| @SpartanTrading | C | +1.30 | 1 | +0.20 |
| @ElliottForecast | C | -1.18 | 1 | +0.80 |
| @proactive_x | C | -1.13 | 1 | +0.20 |
| @OzmosiHealth | C | · | 1 | +0.15 |
Recent signals6of 6 in 14d — receipts included
| date (PT) | author | sent | what they said | since then | receipt |
|---|---|---|---|---|---|
| 2026-10-16 | @BiopharmIQ | +0.00 | The post summarizes opening biotech moves and their company-specific catalysts. | · | tweet ↗ |
| 2026-10-16 | @OzmosiHealth | +0.15 | Tiziana dosed the final patient in a Phase 2 intranasal foralumab Alzheimer's trial. | · | tweet ↗ |
| 2026-10-16 | @proactive_x | +0.20 | Tiziana completed dosing in a Phase 2 Alzheimer's trial of intranasal foralumab. | · | tweet ↗ |
| 2026-10-14 | @ElliottForecast | +0.80 | Bullish long-term structure is said to support a rally toward 937. | · | tweet ↗ |
| 2026-10-06 | @SpartanTrading | +0.20 | Recaps today's long-equity idea results. | · | tweet ↗ |
| 2026-10-03 | @BiopharmIQ | +0.25 | Lists major weekly biotech movers and the company-specific catalysts behind their moves. | · | tweet ↗ |
“Since then” = price move from the close on the signal's date (PT) to the latest close — what happened after they said it, not a backtest. A — means no trading session has closed since the signal yet. Sentiment is our extracted per-tweet score, −1…+1.